Rapid-acting and long-lasting antidepressant-like action of (R)-ketamine in Nrf2 knock-out mice: a role of TrkB signaling
- 12 November 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Archiv Fur Psychiatrie Und Nervenkrankheiten
- Vol. 271 (3), 439-446
- https://doi.org/10.1007/s00406-020-01208-w
Abstract
The transcription nuclear factor-erythroid factor 2-related factor 2 (Nrf2) plays a key role in inflammation that is involved in depression. We previously reported that Nrf2 knock-out (KO) mice exhibit depression-like phenotypes through systemic inflammation. (R)-ketamine, an enantiomer of ketamine, has rapid-acting and long-lasting antidepressant-like effects in rodents. We investigated whether (R)-ketamine can produce antidepressant-like effects in Nrf2 KO mice. Effects of (R)-ketamine on the depression-like phenotypes in Nrf2 KO mice were examined. Furthermore, the role of TrkB in the antidepressant-like actions of (R)-ketamine was also examined. In the tail-suspension test (TST) and forced swimming test (FST), (R)-ketamine (10 mg/kg) significantly attenuated the increased immobility times of TST and FST in the Nrf2 KO mice. In the sucrose preference test (SPT), (R)-ketamine significantly ameliorated the reduced preference of SPT in Nrf2 KO mice. Decreased expression of synaptic proteins (i.e., GluA1 and PSD-95) in the medial prefrontal cortex (mPFC) of Nrf2 KO mice was significantly ameliorated after a single injection of (R)-ketamine. Furthermore, the pre-treatment with the TrkB antagonist ANA-12 (0.5 mg/kg) significantly blocked the rapid and long-lasting antidepressant-like effects of (R)-ketamine in Nrf2 KO mice. Furthermore, ANA-12 significantly antagonized the beneficial effects of (R)-ketamine on decreased expression of synaptic proteins in the mPFC of Nrf2 KO mice. These findings suggest that (R)-ketamine can produce rapid and long-lasting antidepressant-like actions in Nrf2 KO mice via TrkB signaling.Keywords
Funding Information
- Japan Agency for Medical Research and Development (JP20dm0107119)
This publication has 61 references indexed in Scilit:
- Antidepressant Effects of TrkB Ligands on Depression-Like Behavior and Dendritic Changes in Mice After InflammationInternational Journal of Neuropsychopharmacology, 2015
- A review of the relationship between proinflammatory cytokines and major depressive disorderJournal of Affective Disorders, 2014
- Synaptic Dysfunction in Depression: Potential Therapeutic TargetsScience, 2012
- NMDA receptor blockade at rest triggers rapid behavioural antidepressant responsesNature, 2011
- Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in miceJCI Insight, 2011
- Inflammation, Sanitation, and ConsternationArchives of General Psychiatry, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Emerging role of glutamate in the pathophysiology of major depressive disorderBrain Research Reviews, 2009
- From inflammation to sickness and depression: when the immune system subjugates the brainNature Reviews Neuroscience, 2008
- Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)European Neuropsychopharmacology, 1997